Aegis Critical Energy Defence Advances U.S. Expansion with First Installation for Global Biotech Client

Rhea-AI Summary

Aegis Critical Energy Defence (OTCQB: QESSF, CSE: QESS) announced its first U.S. installation, initiating an initial unit of an expected multi-unit program in the Carolinas for a biotechnology facility operated by a top-fifty Japanese multinational. The deployment expands Aegis's U.S. operational footprint and advances its energy-defence strategy. The company also confirmed a management trade restriction has been implemented in line with governance policies and ongoing operational developments.

Positive

• First U.S. installation initiated in the Carolinas
• Deployment for a biotech facility operated by a top‑fifty Japanese multinational

Negative

• No financial metrics disclosed to quantify U.S. expansion impact
• Management trade restriction implemented (potential short‑term insider liquidity limits)

Vancouver, British Columbia--(Newsfile Corp. - February 2, 2026) - Aegis Critical Energy Defence Corp. (CSE: QESS) (OTCQB: QESSF) (FSE: JG6) ("Aegis" or the "Company") is pleased to announce that it has initiated its first installation in the United States.

This initial deployment represents the first unit of what is expected to be a multi-unit installation program in the Carolinas for a biotechnology facility operated by a top-fifty Japanese multinational. The project marks a significant milestone for Aegis as it expands its operational footprint into the U.S. market and advances its strategy of supporting critical infrastructure clients with advanced energy-defence technologies.

The Company also confirms that a management trade restriction has been implemented in accordance with corporate governance policies and ongoing operational developments.

About Aegis Critical Energy Defence Corp.

Aegis Critical Energy Defence Corp. (CSE: QESS) (OTCQB: QESSF) (FSE: JG6) develops and integrates advanced battery energy storage systems for defence, critical infrastructure, industrial, and AI data centre applications. Through strategic partnerships with Indigenous communities and global technology leaders, Aegis delivers rugged, intelligent, and secure energy systems designed for the next generation of mission-critical operations.

Contact Information
Paul Dickson
info@aegiscriticalenergy.com
(604) 283-1262

Forward-Looking Statements

This news release contains statements that constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Aegis Critical Energy Defence Corp.'s actual results, performance or achievements, or developments in the industry to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," "potential" and similar expressions, or that events or conditions "will," "would," "may," "could" or "should" occur.

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/282325

FAQ

What did Aegis (QESSF) announce on February 2, 2026?

Aegis announced its first U.S. installation and a planned multi-unit program in the Carolinas for a biotech client. According to the company, the deployment is for a biotechnology facility operated by a top-fifty Japanese multinational and expands its U.S. footprint further.

How does the Aegis (QESSF) installation affect shareholders and the company outlook?

It signals U.S. market expansion and potential commercial pipeline growth for Aegis, but no financials were provided. According to the company, this initial deployment starts a multi-unit program in the Carolinas and demonstrates operational progress for U.S. clients over time.

What is the scope and client for Aegis's U.S. deployment (QESSF)?

The scope is an initial unit within a multi-unit installation program for a biotech facility. According to the company, the client is a top-fifty Japanese multinational and the work is located in the Carolinas, with additional units expected soon underway.

Why did Aegis (QESSF) implement a management trade restriction and what does it mean for investors?

The company implemented a management trade restriction tied to governance policies and ongoing operational developments. According to the company, the restriction aligns insider trading controls with the new U.S. project milestones and reduces perceived conflict risks for investors short-term period.